Unilife to Participate in the 2014 Annual Leerink Swann Global Healthcare Conference
YORK, Pa., Feb. 10, 2014 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced that its Chairman and CEO, Alan Shortall will present at the Leerink Swann Global Healthcare Conference in New York at 1:50 p.m. EST on Thursday, February 13, 2014 (Friday, February 14th at 5:50 a.m. AEDT).
The event, which is in a fireside chat format, will be broadcast over the Internet as a "live" listen only Webcast. To listen, please go to: http://ir.unilife.com/events.cfm. An archive of the event will also be available for those unable to listen live.
About Unilife Corporation
Unilife Corporation (NASDAQ:UNIS / ASX: UNS) is a U.S. based developer and commercial supplier of injectable drug delivery systems. Unilife's broad portfolio of proprietary technologies includes prefilled syringes with automatic needle retraction, drug reconstitution delivery systems, auto-injectors, wearable injectors, ocular delivery systems and novel systems. Each of these innovative and highly differentiated platforms can be customized to address specific customer, drug and patient requirements. Unilife's global headquarters and state-of-the-art manufacturing facilities are located in York, PA. For more information, please visit www.unilife.com or download the Unilife IRapp on your iPhone, iPad or Android device.
General: UNIS-G
| Investor Contacts (US): |
Analyst Enquiries |
Investor Contacts (Australia) |
| Todd Fromer / Garth Russell |
Lynn Pieper |
Jeff Carter |
| KCSA Strategic Communications |
Westwicke Partners |
Unilife Corporation |
| P: + 1 212-896-1215 / 212-896-1250 |
P: + 1 415-202-5678 |
P: + 61 2 8346 6500 |
SOURCE Unilife Corporation
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article